Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Economic Information Service (CEIS) is a primary subsidiary of the Xinhua News Agency and serves as one of China's largest and most influential providers of economic and financial information. The company operates several major platforms, including the 'Xinhua 08' financial information service, the 'Xinhua Credit' platform, and the 'Belt and Road' economic information service. While CEIS provides extensive data, market intelligence, and analytical reports covering the healthcare and pharmaceutical industries, it is a data and consulting firm rather than a life sciences or biotech company. Its services are primarily utilized by government agencies, financial institutions, and corporate entities for decision-making and market monitoring. For a biotech analyst, CEIS is relevant as a source of Chinese regulatory data, industry indices, and macroeconomic trends affecting the healthcare sector in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Economic Information Service.